overcoming resistance to parpi in brca1-deficient breast cancer with sting agonists
Published 3 years ago • 250 plays • Length 6:40Download video MP4
Download video MP3
Similar videos
-
1:22
overcoming resistance to parp inhibition in ovarian cancer
-
1:52
parpi for somatic brca1/2 and other dna repair gene mutations in women with metastatic breast cancer
-
6:05
mechanisms of resistance to parp inhibitor or platinum chemotherapy in brca1/2 mutated metastati...
-
0:55
overcoming resistance to parp inhibitors in ovarian cancer
-
1:02
how useful are checkpoint inhibitors in the treatment of breast cancer?
-
2:14
javelin parp medley: combining parp inhibitors and immune checkpoint inhibitors
-
2:48
immunomodulatory effects of parp inhibition in brca1-deficient triple-negative breast cancer
-
1:14
endocrine therapy resistance in er metastatic breast cancer
-
2:47
talave: induction talazoparib with parp inhibition in breast cancer
-
2:47
what is a parp inhibitor? | dana-farber cancer institute | science illustrated
-
1:13:00
expanding the benefits of parp inhibitors to more patients with breast cancer and earlier settings
-
4:19
treating brca breast cancer with parp inhibition
-
6:10
role of parp inhibition and i/o therapy in tnbc
-
5:53
combining parp inhibitors checkpoint inhibitors in tnbc
-
3:14
parp inhibitor staves off recurrence in early brca-mutant breast cancer - medpage today
-
0:45
parp inhibitors versus standard of care treatment in breast cancer
-
3:47
parp inhibitory velaparib trialled in brca1/2 breast cancer
-
4:51
telazoparib vs physicians choice for patients with mbrca1 breast cancer
-
1:10
managing metastatic breast cancer and beyond using parp inhibitors